variables | OS | DFS | LRFS | DMFS | ||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
Gender | ||||||||
Female | Ref | Ref | Ref | Ref | ||||
Male | 1.14 (0.66- 1.95) | 0.643 | 1.19 (0.75–1.89) | 0.461 | 1.20 (0.71–2.04) | 0.499 | 1.17 (0.73–1.86) | 0.518 |
Age | ||||||||
< 60 | Ref | Ref | Ref | Ref | ||||
≥ 60 | 1.52 (0.86–2.67) | 0.146 | 1.50 (0.92–2.44) | 0.103 | 1.67 (0.97–2.88) | 0.065 | 1.39 (0.85–2.28) | 0.190 |
CEA | ||||||||
≤ 5 | Ref | Ref | Ref | Ref | ||||
> 5 | 1.00 (1.00–1.01) | 0.358 | 1.00 (1.00–1.01) | 0.435 | 1.00 (1.00–1.01) | 0.596 | 1.00 (1.00–1.01) | 0.355 |
CA199 | ||||||||
≤ 37 | Ref | Ref | Ref | Ref | ||||
> 37 | 1.00 (1.00- 1.01) | 0.414 | 1.00 (1.00–1.00) | 0.878 | 1.00 (1.00–1.00) | 0.567 | 1.00 (1.00–1.00) | 0.810 |
Concurrent chemotherapy regimen | ||||||||
Single | Ref | Ref | Ref | Ref | ||||
Combined | 0.89 (0.50- 1.59) | 0.702 | 0.80 (0.49–1.32) | 0.386 | 0.83 (0.47–1.46) | 0.517 | 0.85 (0.51–1.40) | 0.523 |
None | 0.29 (0.07- 1.22) | 0.092 | 0.04 (1.4e-4–8.95) | 0.237 | 0.24 (0.49–1.16) | 0.076 | 0.05 (0.00–8.25) | 0.249 |
Postoperative chemotherapy | ||||||||
No | Ref | Ref | Ref | Ref | ||||
Yes | 0.82 (0.42–1.60) | 0.559 | 1.11 (0.61–1.99) | 0.741 | 0.96 (0.49–1.86) | 0.897 | 0.99 (0.55–1.77) | 0.972 |
Number of lymph nodes | ||||||||
< 12 | Ref | Ref | Ref | Ref | ||||
≥ 12 | 0.94 (0.56–1.60) | 0.823 | 0.92 (0.58–1.46) | 0.713 | 0.92 (0.55–1.53) | 0.748 | 0.96 (0.60–1.55) | 0.878 |
none | 1.2e-7 (3.3e-8–4.6e-7) | < 2e-16 *** | 1.2e-7 (3.6e-8–3.9e-7) | < 2e-16 *** | 1.3e-7 (3.5e-8–4.6e-7) | < 2e-16 *** | 1.1e-7 (3.4e-8–3.8e-7) | < 2e-16 *** |
Radiotherapy | ||||||||
LCRT | Ref | Ref | Ref | Ref | ||||
LCRT + SIB | 0.70 (0.28–1.77) | 0.447 | 0.81 (0.34–1.89) | 0.618 | 0.76 (0.31–1.86) | 0.542 | 0.77 (0.33–1.80) | 0.542 |
SCRT3 | 4.77 (0.93–24.52) | 0.062 | 29.33 (0.14–62.55) | 0.217 | 5.54 (0.98–31.49) | 0.053 | 22.37 (0.15–33.03) | 0.223 |
Pathological stage | ||||||||
ypCR 0 | Ref | Ref | Ref | Ref | ||||
ypI | 0.49 (0.15–1.55) | 0.222 | 0.95 (0.39–2.33) | 0.913 | 0.65 (0.22–1.90) | 0.431 | 0.79 (0.31–2.01) | 0.615 |
ypII | 1.94 (0.81–4.65) | 0.138 | 2.31 (1.07–4.98) | 0.033 ** | 1.95 (0.84–4.55) | 0.120 | 2.34 (1.07–5.11) | 0.033 * |
ypIII | 3.64 (1.59- 8.34) | 0.002 ** | 4.48 (2.15–9334) | 6.08e-05 *** | 3.83 (1.70–8.61) | 0.001 *** | 4.32 (2.06–9.09) | 0.0001 *** |
Anal canal | ||||||||
Rb group | Ref | Ref | Ref | Ref | ||||
P group | 1.30 (0.76–2.22) | 0.336 | 1.31 (0.82–2.08) | 0.260 | 1.29 (0.76–2.19) | 0.346 | 1.23 (0.78–1.96) | 0.374 |